(Paul DeRose) - Dallas UT Southwestern Medical Center
(Choy Hak) - Dallas UT Southwestern Medical Center
Á¶ÀçÈ£(Cho Jae-ho) - Dallas UT Southwestern Medical Center
Abstract
Locally advanced Non-small cell lung cancer (NSCLC) is a commonly encountered diagnosis. Historically the treatment of locally advanced NSCLC has involved radiation therapy. Clinical trials have shown a benefit to the addition of chemotherapy. In recent years studies have further defined the role of chemotherapy by provided data showing the benefit of concurrent chemotherapy and radiation therapy followed by consolidation with more chemotherapy. Technological advances in radiation therapy have made dose escalation feasible and the current treatment paradigm is now evolving further as dose escalation data becomes available.
Å°¿öµå
Non-small cell lung cancer, Combined modality therapy
KMID :
0982820090080010001
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
the benefit of concurrent chemotherapy and radiation therapy followed by consolidation with more chemotherapy